Amicus Therapeutics 10K Form

Sell

25

FOLD
Amicus Therapeutics

Last Price:

$6.01

Seasonality Move:

23.08%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-09	10Q	FOLD/Amicus Therapeutics Quarterly
2023-11-08	10Q	FOLD/Amicus Therapeutics Quarterly
2023-08-08	10Q	FOLD/Amicus Therapeutics Quarterly
2023-05-10	10Q	FOLD/Amicus Therapeutics Quarterly
2022-11-07	10Q	FOLD/Amicus Therapeutics Quarterly
2022-08-04	10Q	FOLD/Amicus Therapeutics Quarterly

Receive FOLD News And Ratings

See the #1 stock for the next 7 days that we like better than FOLD

FOLD Financial Statistics

Sales & Book Value

Annual Sales:	$528.3M
Cash Flow:	$7.5M
Price / Cash Flow:	1144
Annual Sales:	$0.63
Price / Book:	9.58

Profitability

EPS (TTM):	-0.09000
Net Income (TTM):	$-29.4M
Gross Margin:	$475.4M
Return on Equity:	-17.7%
Return on Assets:	-3.83%

Amicus Therapeutics Earnings Forecast

Key Amicus Therapeutics Financial Ratios

The Gross Profit Margin over the past 22 years for FOLD is 89.98%.
The Selling, General & Administrative Expenses for FOLD have been equal to 61.21% of Gross Profit Margin.
The Research & Development expenses have been 20.70% of Revenue.
The Net Earning history of FOLD is -10.62% of Total Revenues.
Per Share Earnings over the last 22 years have been positive in 12 years.

Amicus Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	FOLD
CUSIP:	03152W
Website:	amicusrx.com

Debt

Debt-to-Equity Ratio:	2.02
Current Ratio:	3.34
Quick Ratio:	2.22

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	7.69

FOLD Technical Analysis vs Fundamental Analysis

Sell

25

Amicus Therapeutics (FOLD) is a Sell

Is Amicus Therapeutics a Buy or a Sell?

Amicus Therapeutics stock is rated a Sell

The current Amicus Therapeutics [FOLD] share price is $6.02. The Score for FOLD is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.